Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Mixed Chimerism Stem Cell Transplantation Utilizing In Vivo and In Vitro Campath for Hemoglobinopathies and Bone Marrow Failure Syndromes

NCT00004143 is registered in ClinicalTrials.gov with David Rizzieri, MD as lead sponsor.

NCT NCT00004143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Mixed Chimerism Stem Cell Transplantation Utilizing In Vivo and In Vitro Campath for Hemoglobinopathies and Bone Marrow Failure Syndromes
Lead sponsor
David Rizzieri, MD
Phase
Phase 2
Overall status
Completed
Start date
September 30, 1999
Completion date
June 30, 2009
Enrollment
2 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal nocturnal hemoglobinuria (pnh), pure red cell aplasia, severe aplastic anemia, sickle cell anemia